All Industries

Top Drug Discovery Companies

1,077 Drug Discovery companies, sorted by total funding raised.

Hydra Biosciences, Inc.Closed

Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in...

Cambridge, United States11–50Biotech, Drug Discovery
Series ETotal funding$72.2MMar 2015
Vilya

Vilya designs novel macrocycle therapeutics using AI-driven computation, combining the targeting ...

Seattle, United States11–50Artificial Intelligence, Biotech
Series ATotal funding$71.0MJun 2024
Edison Scientific

AI platform for scientific discovery enabling researchers to complete literature synthesis, data ...

San Francisco, United States11–50Artificial Intelligence, Deep Tech
SeedTotal funding$70.0MDec 2025
Resource LabelAcquired

Resource Label Group is a national pressure sensitive label, shrink sleeve, and RFID/NFC manufact...

Nashville, United States1001–5000Drug Discovery
Private EquityTotal funding$70.0MMay 2018
Credence

Credence MedSystems develops injectable drug delivery solutions for pharmaceutical and biotechnol...

Menlo Park, United States11–50Healthcare, Drug Discovery
Series DTotal funding$67.6MDec 2024
Sermonix Pharmaceuticals

Privately held biopharmaceutical company developing lasofoxifene, an investigational endocrine th...

Columbus, United StatesBiotech, Drug Discovery
Venture RoundTotal funding$66.0MNov 2021
Adial PharmaceuticalsIPO

Adial Pharmaceuticals develops genetically targeted and colon-targeted drug candidates for patien...

Biotech, Drug Discovery
Corporate RoundTotal funding$64.0MJun 2026
VintaBio
Biotech, Drug Discovery
Series CTotal funding$64.0MApr 2023
AMO Pharma

Privately held biopharmaceutical company developing clinical-stage treatments for neuromuscular a...

Biotech, Drug Discovery
Venture RoundTotal funding$60.0MJan 2020
Ncardia
Biotech, Drug Discovery
Growth EquityTotal funding$60.0MNov 2021
Surge Therapeutics

Develops an injectable intraoperative immunotherapy hydrogel to prevent post-surgical cancer recu...

Cambridge, United States1–10Biotech, Drug Discovery
Series BTotal funding$58.0MJul 2023
Sofie Biosciences, Inc.

SOFIE develops and delivers molecular diagnostics and therapeutics through radiopharmaceutical pr...

Culver City, United States11–50Biotech, Life Sciences
Growth EquityTotal funding$57.4MJun 2024
BiomX

Clinical‑stage company developing natural and engineered bacteriophage cocktails and personalized...

Ness Ziona, Israel51–200Biotech, Drug Discovery
Series BTotal funding$56.0MFeb 2019
Angiochem

Biotech developing EPiC peptide compounds to cross the blood-brain barrier for treating brain dis...

Westmount, CanadaBiotech, Drug Discovery
Series BTotal funding$55.5MSep 2024
Jacobio PharmaIPO

China-based oncology drug discovery company developing induced allosteric inhibitors targeting th...

Beijing, China51–200Oncology, Drug Discovery
Series CTotal funding$55.0MAug 2018
Appia BioClosed

Develops allogeneic CAR‑iNKT cell therapies from hematopoietic stem cells to treat cancers, partn...

Los Angeles, United States11–50Biotech, Drug Discovery
Series ATotal funding$52.0MMay 2021
Rubedo Life

Biotech company discovering and developing medicines targeting pathologic cells that drive aging ...

Sunnyvale, United States11–50Biotech, Healthcare
Series ATotal funding$52.0MApr 2024
Manas AI

AI-native biopharmaceutical company using neuro-symbolic models to accelerate drug discovery for ...

New York, United States1–10Life Sciences, Artificial Intelligence
Extension RoundTotal funding$50.6MSep 2025
Airway Therapeutics

Airway Therapeutics develops zelpultide alfa, a recombinant protein for acute and chronic inflamm...

Biotech, Drug Discovery
Venture RoundTotal funding$50.0MAug 2026
Empress Therapeutics

Biotech company that integrates automated functional genomics, chemoproteomics, and causal machin...

United StatesBiotech, Drug Discovery
Series ATotal funding$50.0MJun 2023
Magnet Biomedicine

Cambridge-based biotech using modular TrueGlue technology to discover molecular glues for the tre...

Cambridge, United StatesBiotech, Drug Discovery
Series ATotal funding$50.0MSep 2023
Vicore Pharma

Clinical-stage biopharmaceutical company developing disease-modifying drugs for respiratory and f...

Biotech, Drug Discovery
Venture RoundTotal funding$48.0MNov 2025
Virobay

Antiviral drug discovery and development company focused on treatments for autoimmune diseases, n...

Menlo Park, United States1–10Biotech, Drug Discovery
Series BTotal funding$48.0MJul 2014
OPHIREX, INC

R&D company with 3 SBIR/STTR awards from Department of Defense.

Corte Madera, United States11–50Biotech, Healthcare
GrantTotal funding$47.7MAug 2023
Ribometrix

Ribometrix develops small molecule drugs that directly target cellular RNAs to correct the levels...

Durham, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$45.3MSep 2019